41
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The impact of patenting on DNA diagnostic practice

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Patents on genes often cover the gene sequence and the link between a disease and mutations in a gene, rather than a technology for the identification of mutations per se. Normally, patents are important for encouraging the development of new diagnostic tools and kits, but there is evidence that they can have severely deleterious effects on the delivery of genetic services. The difference largely depends on the licensing policy of the patent holder. This article describes different ways in which patents are used in this context and how the effects may be mitigated.

          Related collections

          Author and article information

          Contributors
          Role: Head of Molecular Diagnostic Laboratory
          Role: Professor of Cancer Genetics
          Journal
          Clin Med (Lond)
          Clin Med (Lond)
          clinmedicine
          Clinical Medicine
          Royal College of Physicians
          1470-2118
          1473-4893
          01 February 2008
          : 8
          : 1
          : 58-60
          Affiliations
          [1]Center for Human Genetics, University of Leuven, Belgium
          [2]Department of Clinical Development Sciences, St George's, University of London
          Article
          PMC4953711 PMC4953711 4953711 1470-2118(20080201)8:1L.58;1- clinmedicine
          10.7861/clinmedicine.8-1-58
          4953711
          18335671
          6f553696-5240-405f-af21-38d6870abee4
          © 2008 Royal College of Physicians
          History
          Page count
          Pages: 3
          Categories
          Professional Issues
          Custom metadata
          February 2008

          patents,BRCA1,BRCA2,cystic fibrosis transmembrane conductance regulator gene,genetic tests,HFE,license models

          Comments

          Comment on this article